At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
Telehealth +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
In Brief
A clinical study evaluating Telehealth and Control for Acute Myeloid Leukemia and Myelodysplastic Syndromes. Completed, enrolled 36 participants across 1 site.
Detailed Summary
This is a pilot study to evaluate the usability and feasibility of a telehealth-delivered advance care planning intervention among 20 older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Myeloid Leukemia, Myelodysplastic Syndromes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedFeb 2021
Enrollment StartMar 2021
Primary CompletionMar 2023
Study CompletionJul 2023
TodayJul 2026
First PostedFeb 9, 2021
Enrollment StartMar 25, 2021
Primary CompletionMar 1, 2023
Study CompletionJul 12, 2023
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 5.4 years ago
Interventions
Telehealthbehavioral
Telehealth ACP intervention advance care planning intervention
Controlbehavioral
For the control arm, no telehealth visit will be scheduled.